Literature DB >> 21105194

Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma.

Yoshito Tomimaru1, Hiroshi Wada, Shigeru Marubashi, Shogo Kobayashi, Hidetoshi Eguchi, Yutaka Takeda, Masahiro Tanemura, Takehiro Noda, Koji Umeshita, Yuichiro Doki, Masaki Mori, Hiroaki Nagano.   

Abstract

AIM: To investigate whether fresh frozen plasma (FFP) transfusion affects outcomes following hepatic resection for hepatocellular carcinoma (HCC) in terms of liver function, postoperative complications and cancer prognosis.
METHODS: We retrospectively compared the incidence of postoperative complications between 204 patients who underwent hepatectomy for HCC with routine FFP transfusion in an early period (1983-1993, Group A) and 293 with necessity for FFP transfusion during a later period (1998-2006, Group B), and also between two subgroups of Group B [22 patients with FFP transfusion (Group B1) and 275 patients without FFP transfusion (Group B2)]. Additionally, only in limited patients in Group B1 and Group B2 with intraoperative blood loss ≥ 2000 mL (Group B1(≥ 2000 mL) and Group B2(≥ 2000 mL)), postoperative complications, liver function tests, and cancer prognosis were compared.
RESULTS: No mortality was registered in Group B, compared to 8 patients (3.9%) of Group A. The incidence of morbidity in Group B2 [23.2% (64/275)] was not significantly different from Group B1 [40.9% (9/22)] and Group A [27.0% (55/204)]. The incidence of complications and postoperative liver function tests were comparable between Group B1(≥ 2000 mL) vs Group B2(≥ 2000 mL). Postoperative prognosis did not correlate with administration of FFP, but with tumor-related factors.
CONCLUSION: The outcome of hepatectomy for HCC is not influenced by FFP transfusion. We suggest FFP transfusion be abandoned in patients who undergo hepatectomy for HCC.

Entities:  

Mesh:

Year:  2010        PMID: 21105194      PMCID: PMC2992679          DOI: 10.3748/wjg.v16.i44.5603

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Perioperative safety and prognosis in hepatocellular carcinoma patients with impaired liver function.

Authors:  C Y Hsia; W Y Lui; G Y Chau; K L King; C C Loong; C W Wu
Journal:  J Am Coll Surg       Date:  2000-05       Impact factor: 6.113

2.  Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients.

Authors:  M Makuuchi; T Takayama; P Gunvén; T Kosuge; S Yamazaki; H Hasegawa
Journal:  World J Surg       Date:  1989 Sep-Oct       Impact factor: 3.352

3.  Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis.

Authors:  T Nagao; S Inoue; S Goto; T Mizuta; Y Omori; N Kawano; Y Morioka
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

4.  Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer.

Authors:  A G Little; H S Wu; M K Ferguson; C H Ho; V D Bowers; A Segalin; V M Staszek
Journal:  Am J Surg       Date:  1990-12       Impact factor: 2.565

Review 5.  Surgery for small liver cancers.

Authors:  M Makuuchi; T Kosuge; T Takayama; S Yamazaki; T Kakazu; S Miyagawa; S Kawasaki
Journal:  Semin Surg Oncol       Date:  1993 Jul-Aug

6.  Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients.

Authors:  P J Voogt; C J van de Velde; A Brand; J Hermans; T Stijnen; R Bloem; J W Leer; A Zwaveling; J J van Rood
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

7.  Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  J Yamamoto; T Kosuge; T Takayama; K Shimada; S Yamasaki; H Ozaki; N Yamaguchi; S Mizuno; M Makuuchi
Journal:  Surgery       Date:  1994-03       Impact factor: 3.982

8.  The association of perioperative blood transfusion with colorectal cancer recurrence.

Authors:  P I Tartter
Journal:  Ann Surg       Date:  1992-12       Impact factor: 12.969

Review 9.  Adverse reactions to plasma and plasma components.

Authors:  J P Isbister
Journal:  Anaesth Intensive Care       Date:  1993-02       Impact factor: 1.669

10.  Breast cancer survival and perioperative blood transfusion.

Authors:  J P Crowe; N H Gordon; D E Fry; J M Shuck; C A Hubay
Journal:  Surgery       Date:  1989-11       Impact factor: 3.982

View more
  9 in total

Review 1.  Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma.

Authors:  Hisashi Nakayama; Tadatoshi Takayama
Journal:  World J Hepatol       Date:  2015-02-27

2.  Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.

Authors:  Annemiek M Dekker; Jimme K Wiggers; Robert J Coelen; Rowan F van Golen; Marc G H Besselink; Olivier R C Busch; Joanne Verheij; Markus W Hollmann; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2016-01-06       Impact factor: 3.647

3.  Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis.

Authors:  Hiroshi Wada; Hidetoshi Eguchi; Hiroaki Nagano; Shoji Kubo; Takuya Nakai; Masaki Kaibori; Michihiro Hayashi; Shigekazu Takemura; Shogo Tanaka; Yasuyuki Nakata; Kosuke Matsui; Morihiko Ishizaki; Fumitoshi Hirokawa; Koji Komeda; Kazuhisa Uchiyama; Masanori Kon; Yuichiro Doki; Masaki Mori
Journal:  Surg Today       Date:  2017-06-08       Impact factor: 2.549

Review 4.  Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions.

Authors:  J P Cata; H Wang; V Gottumukkala; J Reuben; D I Sessler
Journal:  Br J Anaesth       Date:  2013-05       Impact factor: 9.166

Review 5.  Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review.

Authors:  Sibylle Kozek-Langenecker; Benny Sørensen; John R Hess; Donat R Spahn
Journal:  Crit Care       Date:  2011-10-14       Impact factor: 9.097

6.  Intraoperative Transfusion of Fresh Frozen Plasma Predicts Morbidity Following Partial Liver Resection for Hepatocellular Carcinoma.

Authors:  Jan Bednarsch; Zoltan Czigany; Isabella Lurje; Christian Trautwein; Tom Lüdde; Pavel Strnad; Nadine Therese Gaisa; Alexandra Barabasch; Philipp Bruners; Tom Ulmer; Sven Arke Lang; Ulf Peter Neumann; Georg Lurje
Journal:  J Gastrointest Surg       Date:  2020-06-03       Impact factor: 3.452

Review 7.  Perioperative Management of Complex Hepatectomy for Colorectal Liver Metastases: The Alliance between the Surgeon and the Anesthetist.

Authors:  Enrico Giustiniano; Fulvio Nisi; Laura Rocchi; Paola C Zito; Nadia Ruggieri; Matteo M Cimino; Guido Torzilli; Maurizio Cecconi
Journal:  Cancers (Basel)       Date:  2021-05-03       Impact factor: 6.639

8.  Impact of low skeletal muscle mass index and perioperative blood transfusion on the prognosis for HCC following curative resection.

Authors:  Tomoaki Bekki; Tomoyuki Abe; Hironobu Amano; Minoru Hattori; Tsuyoshi Kobayashi; Masahiro Nakahara; Hideki Ohdan; Toshio Noriyuki
Journal:  BMC Gastroenterol       Date:  2020-10-07       Impact factor: 3.067

9.  Hemodynamic Consequences of Malignant Ascites in Epithelial Ovarian Cancer Surgery*: A Prospective Substudy of a Randomized Controlled Trial.

Authors:  Oliver Hunsicker; Christina Fotopoulou; Klaus Pietzner; Mandy Koch; Alexander Krannich; Jalid Sehouli; Claudia Spies; Aarne Feldheiser
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.